What are Citracal products used for? Your bones are constantly being broken down and rebuilt again, with calcium being a key player in bone strength. Citracal products are used to increase calcium ...

Bayer HealthCare announced today that its Consumer Care Division has completed its previously announced acquisition of the U.S. line of Citracal over-the-counter calcium supplements from Mission ...

CITRACAL PLUS BONE DENSITY BUILDER prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

MORRISTOWN, N.J. Bayer HealthCare Friday morning announced that its Consumer Care Division has received regulatory approvals necessary to acquire the Citracal line of over-the-counter calcium ...

Plant-derived DHA omega-3 fatty acid boosts fetal nutrition - SAN ANTONIO, March 9 /PRNewswire/ -- Mission Pharmacal Company, makers of Citracal(R) brand of calcium citrate supplements and prenatal ...

CITRACAL CALCIUM PLUS HEART HEALTH by Bayer Consumer Care Citracal Calcium Plus Heart Health (calcium, elemental [as carbonate and citrate], vitamin D [as cholecalficerol], phytosterols) has been made ...

Citracal UltraDense calcium citrate, Mission's flagship brand, has been cited in numerous clinical studies for its optimal solubility, and its proven ability to help stop bone loss. Citracal has ...

FRANKFURT, Aug 30 (Reuters) - Bayer has agreed to buy the Citracal line of over-the-counter calcium supplements from U.S. Mission Pharmacal Company for an undisclosed sum, the German drug and ...

Osteoporosis, a prevalent health issue affecting millions globally, leads to the weakening of bones, thereby raising the chances of fractures. A typical strategy to enhance bone health involves taking ...

SAN ANTONIO, Aug. 30 /PRNewswire/ -- Mission Pharmacal, the privately held specialty pharmaceutical company that researched and commercialized Citracal(R) calcium citrate supplements, then turned them ...

In Bayer Healthcare LLC v OHIM, the CFI has upheld a decision of the Board of Appeal of OHIM in which the latter had found that there was a likelihood of confusion between the marks CITRACAL and ...